Cargando…
Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: Yes
Autores principales: | Reindl, Markus, Rostasy, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338689/ https://www.ncbi.nlm.nih.gov/pubmed/37227111 http://dx.doi.org/10.1177/13524585231172954 |
Ejemplares similares
-
Serum MOG-IgG titers should be performed routinely in the diagnosis and follow-up of MOGAD: Commentary
por: Gastaldi, Matteo, et al.
Publicado: (2023) -
Low-dose rituximab should be used for treating MS in resource-limited
settings: Yes
por: Piehl, Fredrik, et al.
Publicado: (2022) -
Stable multiple sclerosis patients on anti-CD20 therapy should go on extended
interval dosing—“Yes”
por: Rolfes, Leoni, et al.
Publicado: (2021) -
Studying the blood–brain barrier will provide new insights into neurodegeneration – Yes
por: Kamphuis, Wouter W, et al.
Publicado: (2018) -
Much, if not all, of the cortical damage in MS can be attributed to the microglial cell – Yes
por: van Wageningen, Thecla A, et al.
Publicado: (2018)